3,3',4'-trihydroxyflavone has been researched along with scutellarein in 2 studies
Studies (3,3',4'-trihydroxyflavone) | Trials (3,3',4'-trihydroxyflavone) | Recent Studies (post-2010) (3,3',4'-trihydroxyflavone) | Studies (scutellarein) | Trials (scutellarein) | Recent Studies (post-2010) (scutellarein) |
---|---|---|---|---|---|
39 | 0 | 22 | 139 | 1 | 97 |
Protein | Taxonomy | 3,3',4'-trihydroxyflavone (IC50) | scutellarein (IC50) |
---|---|---|---|
Histone-lysine N-methyltransferase NSD2 | Homo sapiens (human) | 2.65 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 3.02 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.02 | |
Alpha-amylase 1A | Homo sapiens (human) | 9.64 | |
G protein-coupled receptor kinase 6 | Homo sapiens (human) | 6.61 | |
Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 2.92 | |
Receptor-type tyrosine-protein phosphatase S | Homo sapiens (human) | 0.6 | |
Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | 1.96 | |
Histone-lysine N-methyltransferase EZH1 | Homo sapiens (human) | 8.77 | |
Aurora kinase B | Homo sapiens (human) | 3.85 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Eom, S; Hwang, DS; Hyun, J; Jo, G; Lee, Y; Lim, Y; Park, JC; Woo, Y | 1 |
Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
2 other study(ies) available for 3,3',4'-trihydroxyflavone and scutellarein
Article | Year |
---|---|
Relationships between structures of hydroxyflavones and their antioxidative effects.
Topics: Antioxidants; Flavones; Flavonoids; Flavonols; Free Radical Scavengers; Models, Molecular; Quantitative Structure-Activity Relationship | 2010 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |